Repression of E-cadherin by the polycomb group protein EZH2 in cancer

By Q. Cao, Jindan Yu, S. Dhanasekaran, J. H. Kim, R. Mani, S. Tomlins, R. Mehra, B. Laxman, Xuhong Cao, C. Kleer and 2 more. Oncogene, 2008

602 citations recorded by the source corpus.

Subfields: Molecular Biology

View Paper: https://www.semanticscholar.org/paper/f419959f3b61e4cb235c2730304c04908836b345

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Molecular Biology

1. Arul M. Chinnaiyan
2. C. Abate-Shen
3. Zhaohui S. Qin
4. M. Shen

Citations in the corpus

• An Integrated Network of Androgen Receptor, Polycomb, and TMPRSS2-ERG Gene Fusions in Prostate Cancer Progression (2010, methodology): “ChIP-Seq analysis demonstrated ERG binding to a number of previously reported EZH2 target genes such as ADRB2, CDH1, DAB2IP, SNCA, and SOCS (Cao et al., 2008; Chen et al., 2005; Yu et al., 2007b) (Figure S6B).”
• Molecular genetics of prostate cancer: new prospects for old challenges. (2010, background): “Other EZH2 target genes in prostate cancer are associated specifically with metastasis, including E-cadherin (Cao et al. 2008) and DAB2IP (H Chen et al. 2005), which promotes prostate cancer metastasis through activation of Ras and NF-kB pathways (Min et al. 2010).”